BioTechnology News
- White House Asks Court: Unfreeze Stem Cell $$ Tuesday, August 31, 2010 @ 6:49PMThe Obama administration was a judge to allow federal funding of embryonic stem cell research to resume. Stem cell - Embryonic stem cell - Biotechnology - Biology - Stem Cell Research
- Chinese researcher charged with stealing US trade secrets Tuesday, August 31, 2010 @ 6:31PMA Chinese researcher has been arrested and charged with stealing trade secrets about insecticides from US biotech company Dow and passing them on to China, court documents showed Tuesday.
- Obama administration appeals stem cell injunction Tuesday, August 31, 2010 @ 6:27PMWASHINGTON (Reuters) - The Obama administration asked a federal judge on Tuesday to lift an injunction halting human embryonic stem cell research, saying it would irreparably harm research and cost more than 1,300 jobs.
- 8. Senai Hi-tech park to focus on three areas Tuesday, August 31, 2010 @ 6:23PMSENAI: Senai High Tech Park Sdn Bhd (SHTP), the operator of Senai Hi-Tech Park project, is focusing on three key areas as the driving factors to spearhead the development of the park.
- Fenton copes with life after Chrysler Tuesday, August 31, 2010 @ 6:02PMHot Shots Sports Bar & Grill in Fenton rarely is hurting for customers, according to its general manager.
- Portfolio Tuesday, August 31, 2010 @ 5:31PMTom Andrews, publisher of the Picayune Item and the weekly Poplarville Democrat, is retiring today after 32 years with the newspapers.
- Final Glance: Biotechnology companies Tuesday, August 31, 2010 @ 5:17PMAmgen fell $.59 or 1.1 percent, to $51.04. Biogen Idec fell $.12 or .2 percent, to $53.80.
- Medicare Meeting A Good Sign For Dendreon Tuesday, August 31, 2010 @ 5:12PMIt's positive that Medicare scheduled a meeting so rapidly, and that the meetings focus will be rest
- Final Glance: Biotechnology companies Tuesday, August 31, 2010 @ 5:07PMNEW YORK (AP) -- Shares of some top biotechnology companies were mixed at the close of trading: Amgen fell $.59 or 1.1 percent, to $51.04. Biogen Idec fell $.12 or .2 percent, to $53.80. Celgene rose $.63 or 1.2 percent, to $51.47. Gilead Sciences fell $.59 or 1.8 percent, to $31.83.
- Stocks to watch: Affco, Contact, Fletcher Tuesday, August 31, 2010 @ 4:47PMTalley's has lifted its holding in Affco to 79.1%, Contact Energy management's outlook compensates for its disappointing earnings, while Fletcher Building shares fell 1.2% yesterday on news residential property consents retreated back into negative figures after reaching positive territory the previous month.
- Scientists suggest immunization against viruses can prevent cancer Thursday, August 19, 2010 @ 2:19AMViruses that can invade host cells, initiate cancer and then flee fromb their own trail of destruction could be stopped in their tracks, say researchers writing in the September issue of the Journal of General Virology.
- Advaxis enters veterinary study contract with University of Pennsylvania School of Veterinary Medicine Thursday, August 19, 2010 @ 1:42AMAdvaxis, Inc., , the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company and the University of Pennsylvania School of Veterinary Medicine have signed a veterinary clinical research study contract to treat osteosarcoma in companion dogs using Advaxis' technology.
- UAE to get stem cell treatment and research unit Thursday, August 19, 2010 @ 1:15AMProteonomix, a biotechnology company focused on developing therapeutics based on the use of human cells and their derivatives, has executed a joint venture agreement with a group of investors that will create a new stem cell treatment and research facility in the UAE.
- Tropical Bioessence to export essential oils to France Thursday, August 19, 2010 @ 1:14AMMELAKA: Tropical Bioessence Sdn Bhd (Tropical Bioessence), a subsidiary of Malacca Biotechnology Corporation (MBC), will soon export herbal and food-based oil extracts to France, once the corporation’s manufacturing plant is ready in September.
- FCC serves up breakfast, business appreciation Thursday, August 19, 2010 @ 1:00AMThree businesses and an individual were recognized for their achievements Wednesday at Frederick Community College's inaugural Business Appreciation Breakfast
- Zimbabwe: Support for Young Scientists Vital Thursday, August 19, 2010 @ 12:45AMYoung African researchers need to be supported and encouraged through the promotion of high-level training and ensuring their professional integration into the scientific community, Prof Christopher Chetsanga, a renowned biochemist said.
- Norwich scientists' fat discovery offers new hope to slimmers Thursday, August 19, 2010 @ 12:39AMScientists at the Institute of Food Research (IFR) at Norwich Research Park researching the way the body breaks down fat have an important discovery. Their breakthrough provides a focus to find ways to slow down fat digestion, and ultimately to create food structures that make people feel full.
- Special to the Daily Herald Thursday, August 19, 2010 @ 12:12AMThe Temple College Texas Bioscience Institute inducted its fifth class Wednesday night at a white coat ceremony at the Mary Alice Marshall Performing Arts Center on campus.
- Avista Said to Purchase Drug Tester INC for About $600 Million Wednesday, August 18, 2010 @ 11:44PMAvista Capital Partners and Ontario Teachers’ Pension Plan agreed to buy INC Research Inc., a drug development contractor for pharmaceutical and biotechnology companies, for about $600 million, according to a person with direct knowledge of the matter.
- FDA grants orphan drug designation to ImmunoGen's lorvotuzumab mertansine for small-cell lung cancer Wednesday, August 18, 2010 @ 11:34PMImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC).
- The True Cost of Coal: an illustration by The Beehive Collective is coming to Portland Wednesday, August 18, 2010 @ 6:51PMLearn more about the impacts of mountaintop removal coal mining through the eyes of artists who interviewed hundreds of people in the Appalachian region.
- New hope for superbug drugs Wednesday, August 18, 2010 @ 6:41PMSix-year-old Sarah Kerr has spent almost 100 days of her young life in hospital receiving intensive antibiotic treatment to keep at bay life-threatening respiratory infections.
- Is engineered 'Frankenfish' coming to the nation's table? Wednesday, August 18, 2010 @ 6:23PMWith a global population pressing against food supplies and vast areas of the ocean swept clean of fish, tiny AquaBounty Technologies Inc. of Waltham, Mass., says it can help feed the world.
- Education news Wednesday, August 18, 2010 @ 5:37PMSachin R. Rudraraju, a sophomore at Olentangy Liberty High School, has been selected to receive the Ohio Academy of Science Governor's Award for excellence in information science and technology research.
- Final Glance: Biotechnology companies Wednesday, August 18, 2010 @ 5:21PMAmgen rose $.19 or .3 percent, to $54.14. Biogen Idec fell $.39 or .7 percent, to $56.52.
- Researchers gather to discuss future of research Wednesday, August 18, 2010 @ 5:14PMThe country’s largest independent research organisation, Cawthron Institute, has called scientists and researchers from all over New Zealand together to develop strategies for on-going research into the discovery of the deadly tetrodotoxin in Auckland.
- Final Glance: Biotechnology companies Wednesday, August 18, 2010 @ 5:02PMNEW YORK (AP) -- Shares of some top biotechnology companies were mixed at the close of trading: Amgen rose $.19 or .3 percent, to $54.14. Biogen Idec fell $.39 or .7 percent, to $56.52. Celgene fell $.22 or .4 percent, to $55.17. Gilead Sciences fell $.39 or 1.1 percent, to $33.77.
- PepsiCo deal boosts Senomyx financial outlook Wednesday, August 18, 2010 @ 5:01PMThe San Diego company's losses for the year will shrink thanks to the initial effects of the $62 million, four-year partnership with the global drink giant.
- Support for young scientists vital Wednesday, August 18, 2010 @ 4:27PMYOUNG African researchers need to be supported and encouraged through the promotion of high-level training and ensuring their professional integration into the scientific community, Prof Christopher Chetsanga, a renowned biochemist said.
- ImmunoGen's Small-Cell Lung Cancer Treatment Receives Orphan Drug Designation Wednesday, August 18, 2010 @ 4:24PMImmunoGen, Inc. said Wednesday that a drug used to treat small-cell lung cancer has been granted orphan drug designation by the US Food and Drug Administration.
- Sanofi-Aventis, Genzyme discuss possible acquisition: Wall Street Journal Friday, July 23, 2010 @ 6:21PMINDIANAPOLIS - Shares of Genzyme Corp. soared Friday after a report was published that French pharmaceutical company Sanofi-Aventis is interested
- Report: Sanofi-Aventis, Genzyme talk acquisition Friday, July 23, 2010 @ 6:12PM(AP:INDIANAPOLIS) Shares of Genzyme Corp. soared Friday after a report was published that French pharmaceutical company Sanofi-Aventis is interested in the biotechnology drugmaker.
- Stocks rise after Euro bank tests, earnings Friday, July 23, 2010 @ 5:43PMInvestors bought stocks again on the latest reassuring news about the economy. This time, it was about European banks.
- Final Glance: Biotechnology companies Friday, July 23, 2010 @ 5:37PMAmgen fell $.56 or 1.1 percent, to $52.75. Biogen Idec fell $2.70 or 4.8 percent, to $53.47.
- BioMed Realty Trust to Report 2010 Second Quarter Results Friday, July 23, 2010 @ 5:35PMSAN DIEGO----BioMed Realty Trust, Inc. today announced it will report results for its second quarter ended June 30, 2010 after the market closes on Wednesday, July 28, 2010.
- Earnings, Europe boost stocks Friday, July 23, 2010 @ 5:30PMDow see two-day gain grow to more than 300 points
- Momenta receives OK for generic version of Lovenox Friday, July 23, 2010 @ 5:20PMBiotechnology company Momenta Pharmaceuticals Inc. said Friday the U.S. Food and Drug Administration approved its generic version of Sanofi-Aventis SA's Lovenox, an injected drug for preventing life-threatening blood clots. 0 - g - F
- Momenta receives OK for generic version of Lovenox Friday, July 23, 2010 @ 5:12PM(AP:TRENTON, N.J.) Biotechnology company Momenta Pharmaceuticals Inc. said Friday the U.S. Food and Drug Administration approved its generic version of Sanofi-Aventis SA's Lovenox, an injected drug for preventing life-threatening blood clots.
- Stocks rise after Euro bank tests, earnings Friday, July 23, 2010 @ 5:11PMInvestors bought stocks again on the latest reassuring news about the economy. This time, it was about European banks. European regulators, who issued the results of what are called "stress tests" on the banks, said Friday that only a handful would struggle if the continent's economy weakens.
- Final Glance: Biotechnology companies Friday, July 23, 2010 @ 5:10PMNEW YORK (AP) -- Shares of some top biotechnology companies were mixed at the close of trading: Amgen fell $.56 or 1.1 percent, to $52.75. Biogen Idec fell $2.70 or 4.8 percent, to $53.47. Celgene rose $.41 or .8 percent, to $52.75. Gilead Sciences fell $.36 or 1.1 percent, to $33.42.
- How memory is disrupted in those with disease linked to learning disabilities Saturday, July 17, 2010 @ 9:29PMImagine if your brain lost its working memory -- the ability to hold and manipulate information in your mind's eye. That's the plight faced by millions of people with neurofibromatosis type 1, or NF1. Now a UCLA research team has uncovered new clues about how NF1 disrupts working memory. Their findings suggest a potential drug target for correcting NF1-related learning disabilities.
- Cell signaling classification system gives researchers new tool Saturday, July 17, 2010 @ 9:29PMUsing ever-growing genome data, scientists are tracing the evolution of the bacterial regulatory system that controls cellular motility, potentially giving researchers a method for predicting important cellular functions that will impact both medical and biotechnology research.
- Patrick struggles to meet great expectations Saturday, July 17, 2010 @ 8:35PMA week after her 13-year-old son, Steven, was shot to death on his way home from playing basketball, Kim Odom stood in the rain outside her Dorchester home and cried out for the governor. Dorchester Boston - Basketball - Dorchester - Murder - Boston
- Majority of US consumers consider sustainability, survey finds Saturday, July 17, 2010 @ 5:28PMConsumers polled in the survey rated less pesticide spraying on crops as the most important factor when considering sustainability, followed by better soil health and improved water quality.
- What the big players make Saturday, July 17, 2010 @ 3:57PMThe crushing economic downturn - and an uneven and sporadic recovery - hit not only rank-and-file workers, but also the top echelons of corporate boardrooms. The Baltimore Sun analyzed compensation packages at 18 publicly traded companies in the metro area that paid CEOs at least $1 million last year, including (from left): Mayo Shattuck, Constellation Energy Group ($10,910,105); A.E. Festa, W.R ...
- Teachers become students at science camp Saturday, July 17, 2010 @ 11:32AMCHERYL BURKE
- Clean-tech, biotech help VC funding soar Saturday, July 17, 2010 @ 7:36AMVenture capital funding in the second quarter jumped to the highest level in almost two years, as investors increased their bets on alternative energy and biotechnology. Firms invested $6.52 billion in the United States during the period, a 53 percent... Venture capital - United States - Biotechnology - Business - Clean technology
- Africa: Continent's Market-Led Development - Pro-Corporation, Anti-Farmer Saturday, July 17, 2010 @ 7:23AMUSAID administrator Rajiv Shah recently gave a speech to the US Global Leadership Coalition (USGLC) in Washington DC entitled 'Achieving high impact development: a vision for USAID'. Shah's idea of high-impact development was a 'distinctly American' contribution: the 'culture of risk-taking and entrepreneurship'. In a speech heavy with platitudes about American diversity, dedication and ...
- Bu$ine$$ Briefs Saturday, July 17, 2010 @ 7:17AMStage set for Fifth Annual Hubert J.P. Schoemaker Classic
- Develop RP’s biotechnology, Angara urges Saturday, July 17, 2010 @ 6:36AMSenator Edgardo J. Angara urged the Departments of Health (DoH) and Science and Technology (DoST) on Saturday to work together in harnessing the country’s biotechnology potentials and improve the country’s health care system.
